近些年来，非典型抗精神病药物已逐渐作为首选药物广泛应用于各类精神疾病的治疗，尤其是用于初发病患者，其中又以利培酮、再普乐和思瑞康最受欢迎。
这是FDA首次批准的用于青少年精神疾病的非典型抗精神病药物。
This is the first FDA approval of an atypical antipsychotic drug to treat either disorder in these age groups.
结果非典型抗精神病药物虽被广泛应用，但不同医院使用品种不同。
Results Atypical neuroleptics were used widely, but there were different kinds in different hospitals.
没有证据表明饮食失调、物质滥用或失眠与使用非典型抗精神病药物相关。
No evidence was found for use of atypical antipsychotics for eating disorders, substance abuse, or insomnia.
应用推荐